Skip to main navigation Skip to search Skip to main content

No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life

  • Anne M. Plomgaard
  • , Thomas Alderliesten
  • , Frank van Bel
  • , Manon Benders
  • , Olivier Claris
  • , Malaika Cordeiro
  • , Eugene Dempsey
  • , Monica Fumagalli
  • , Christian Gluud
  • , Simon Hyttel-Sorensen
  • , Petra Lemmers
  • , Adelina Pellicer
  • , Gerhard Pichler
  • , Gorm Greisen
  • University of Copenhagen
  • Utrecht University
  • Universite Claude Bernard Lyon 1
  • Hospital Universitario La Paz
  • University of Milan
  • Medical University of Graz

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life'. Together they form a unique fingerprint.
Sort by

Neuroscience